Health Condition 1: I219- Acute myocardial infarction, unspecified
Conditions
Interventions
None listed
Sponsors
Rohit Srivastava
Eligibility
Inclusion criteria
Inclusion criteria: Leftover plasma from venous blood of suspected/ at-risk patients with ACS, COVID-19 and other conditions for which testing for cardiac troponins are requested by physicians. a) Acute coronary syndrome b) Acute respiratory infection c) COVID-19 d) Pulmonary hypertension e) Pulmonary embolus f) Congestive heart failure g) Coronary artery spasm h) Tachyarrhythmias i) Myocarditis j) Kidney disease k) Prolonged exercise l) Trauma that injures the heart m) Cardiomyopathy n) Cardiac angioplasty/stenting o) Heart defibrillation or electrical cardioversion p) Open heart surgery q) Radiofrequency ablation of the heart r) Rhabdomyolysis and polymyositis
Exclusion criteria
Exclusion criteria: a) Patients not willing to participate in the study b) Specimen prepared incorrectly c) Those with labelling problems d) Temperature not maintained for specimen. e) Samples received >4 hours after collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure the ability of TropChek to detect cTnT and cTnI in the plasma and compared with Reference IVD.Timepoint: One-time | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Diagnostic Sensitivity 2 Diagnostic Specificity 3 Positive Predictive Value 4 Negative Predictive Value 5 Likelihood Ratio 6 Accuracy or probability of a correct test result. 7 ReproducibilityTimepoint: One-time | — |
Countries
India
Contacts
Public ContactRohit Srivastava
IIT Bombay
Outcome results
None listed